Matthew L. Posard

Matthew L. Posard

DirectoratHalozyme Therapeutics· In proxies 2023–2025

Matthew L. Posard sits on 7 public boards.

Boards1

  • Halozyme TherapeuticsDirector · 11 yr on the boardIndependentAudit, Nominating and Corporate Governance (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Halozyme TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +128%
  2. Company’s Board of DirectorsPublic company
    • Director? – PresentNo stock prices for these years
  3. DermTech, Inc. (Chairman)Public company
    • Director? – PresentNo stock prices for these years
  4. Directors:Public company
    • Director? – PresentNo stock prices for these years
  5. Nautilus Biotechnology, Inc., (Chairman) a development stage life sciences companyPublic company
    • Director? – PresentNo stock prices for these years
  6. Recent Past Public Company Board ExperiencePublic company
    • Director? – PresentNo stock prices for these years
  7. Talis BiomedicalPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?